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Abstract
Regulation of α- and β-actin Isoforms in the Contracting
A7r5 Smooth Muscle Cell
By Dawn Leah Brown-Turner
Two isoforms of actin have been found to be present in A7r5 smooth muscle cells, α- and
β-actin. This body of work sets out to examine the different regulatory factors of the two
actin isoforms during smooth muscle contraction. The response of the actin isoforms to
phorbol 12, 13-dibutyrate (PDBu) is markedly different. α-Actin remodels to podosomes
around the periphery of the cell, while β-actin merely shortens. One protein involved in
smooth muscle contraction induced by PDBu is protein kinase C (PKC). Two inhibitors
of PKC, staurosporine and bisindolymaleimide, were used prior to PDBu stimulation and
after PDBu stimulation to observe the effects of PKC on α- and β-actin stress fiber
structure and remodeling. α-Actin showed a decrease in podosome formation when the
inhibitors were added prior to or after PDBu stimulation. β-actin demonstrated a loss in
stress fiber structure in response to PKC inhibitors. PKC appears to regulate α- and βactin differently and could play a role in the differential remodeling seen by these two
actin isoforms. Myosin light chain kinase (MLCK) is another enzyme involved in
smooth muscle contraction. Even though it does not play a major role in PDBu induced
contraction of smooth muscle, it has been found to interact with actin at two different
actin binding sites, allowing crosslinking of actin filaments. Inhibition of the kinase
domain of MLCK does not seem to have an effect on the crosslinking abilities of MLCK.
These two key enzymes of smooth muscle contraction appear to not only be able to
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initiate smooth muscle contraction, but also regulate reorganization of the two actin
isoforms during smooth muscle contraction.
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Chapter I
General Introduction
Dissertation Organization
This dissertation is divided into four chapters. The first chapter is an overview of
the organization of the dissertation followed by a literature review of important topics
that will be discussed in the following chapters. Chapter two is a manuscript that was
published in the Canadian Journal of Physiology and Pharmacology. In this manuscript
I investigated the regulatory role of protein kinase C (PKC) on α- and β-actin prior to and
following initiation of contraction by phorbol 12, 13-dibutyrate (PDBu). In the third
chapter, I investigated whether the kinase domain of myosin light chain kinase (MLCK)
plays a role in the crosslinking of actin filaments. Chapter four is an overview of the
results found in the experiments conducted within this body of work, as well as a look
into what future endeavors could be examined.

Actin Isoforms
Actin is an abundant protein in all eukaryotic cell types. It is a cytoskeletal
protein that plays a role in numerous functions including maintaining cell shape, cell
division, endocytosis, exocytosis, secretion, signal transduction, and regulation of
enzyme activities (Pollard and Cooper, 1976; Welch et al., 1998). Of interest to the
current work is the role actin plays in vascular smooth muscle contraction.
There are six actin isoforms known to be expressed in mammalian cells. Each of
these six isoforms is encoded by an individual gene (Vandekerckhove and Weber,
1978a). These six isoforms can be classified into three groups based on isoelectric
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focusing; α-, β-, and γ-actins (Garrels and Gibson, 1976; Storti et al., 1976; Wahlen et
al., 1976; Rubenstein and Spudich, 1977). The three classes of isoforms are highly
conserved with less than 10% difference between the amino acid sequences (Erba et al.,
1988; Gunning et al., 1983; Hamada et al., 1982; Ng et al., 1985; Vandekerckhove and
Weber, 1978a). Sequence analysis conducted by Vandekerckhove and Weber (1978b)
indicated that most of the variability in the amino acid sequences arises within the first
several amino acids of the amino-terminal region. α-Actin contains four charged amino
acid residues within the first several amino acids of the amino-terminal region. By
comparison, β-actin has three acidic residues, Asp-Asp-Asp, in the amino-terminal
region. Like β-actin, γ-actin has three acidic residues as well in the amino-terminal
region, but they are Glu-Glu-Glu. While there are other differences in the amino acid
sequence spread throughout the molecule of the various isoforms of actin, it is the
differences in the amino-terminal region that are likely to determine the specific functions
and/or interactions of the isoforms, including actin-actin, acto-myosin, and actin-actinbinding protein interactions (Herman, 1993).
Another way to classify the actin isoforms is based on whether they are
contractile or cytoplasmic actins. Contractile actins, or muscle actins, play a role in
muscle contraction. All α-actin isoforms are contractile proteins. Cytoplasmic actins are
also known as non-muscle actins, meaning they are not thought to play a role in muscle
contraction, but rather play a structural support role in the cell. β-actin is a cytoplasmic
actin. γ-actins have isoforms that can fit into either of these groups (Mossakowska and
Strzelecka-Golaszewska, 1985).

2

Smooth muscle has been found to express four actin isoforms. Two of the
isoforms are smooth muscle (SM) specific α-SM and γ-SM actins, while the other two
are non-muscle (NM) actins, β-NM and γ-NM actins (Drew and Murphy, 1997). Of the
two smooth muscle specific actins, α-SM actin is the isoform found predominantly in
vascular smooth muscle, comprising up to 70% of the total actin (Fatigati and Murphy,
1984; Small, 1995). Of the two cytoplasmic actins, β-actin is more abundant in vascular
smooth muscle (Franke et al., 1980; Owens et al., 1986; Skalli et al., 1987). All four
isoforms, however, can be found in vascular smooth muscle during fetal development
with β-actin being the predominant isoform (Franke et al., 1980; Owens et al., 1986;
Skalli et al., 1987). The switch from predominantly β-actin to α-actin marks the
differentiation of smooth muscle cells (Owens and Thompson, 1986; Skalli et al., 1987).
Cells that have undergone differentiation are generally non-dividing cells that have the
ability to contract (Murphy, 1992). An interesting phenomenon that has been
documented is the switching from α-actin as the predominant isoform back to β-actin as
the predominant isoform after differentiation of the smooth muscle cells. This
phenomenon is known as dedifferentiation and results in loss of contractility. Some
instances where this has been found include during isolation of cells for primary culture
(Chamley-Campbell et al., 1979; Chamley-Campbell et al., 1981; Yau-Young et al.,
1981), during cell proliferation and migration (Barja et al., 1986), and during conditions
like intimal thickening of rat aorta after endothelial injury or human atheromatous plaque
development (Gabbiani et al., 1984).
With the presence of multiple actin isoforms within a given cell type, a common
question arises as to why a cell would have multiple forms of a protein that is so similar
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in amino acid sequence and thus structure. The two common topics that attempt to
answer this question revolve around the location of the isoforms in the cell and the
function of the isoforms in the cell.
Many studies have looked at the possibility of compartmentalization of the
various actin isoforms within a given cell type. As mentioned previously, the actin
isoforms are often referred to as contractile or cytoplasmic actins. Results from some of
these studies indicate that the actin is compartmentalized in such a way as to yield
contractile domains and cytoplasmic domains. According to work conducted by Small et
al. (1986) and Draeger and co-workers (1990), the contractile domains are distinguished
by the presence of actin and myosin, while the cytoskeletal domains are distinguished by
actin, intermediate filaments, and dense bodies. Another study by Lehman (1991) also
indicated two distinct populations of actin filaments that were isolated from smooth
muscle cells using two distinct antibodies. The use of an anti-filamin antibody revealed
actin filaments associated with tropomyosin, filamin, and calponin. The presence of
filamin, an intermediate filament protein, suggests that this set of actin filaments would
be part of the cytoskeletal domain. The use of an anti-caldesmon antibody resulted in
actin filaments associated with tropomyosin and caldesmon. Caldesmon is known to
modulate contractile activity, suggesting that this set of actin filaments would be part of
the contractile domain.
In some instances, spatial separation of the actin isoforms in smooth muscle has
been found. DeNorfrio et al. (1989) and Herman (1993) have both found α-actin to be
present in stress fibers, while NM-actins are localized to regions of advancing cortical
cytoplasm within vascular smooth muscle cells in culture. Similarly, North et al. (1994)
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found that in chicken gizzard smooth muscle cells, the two actin isoforms, β-NM-actin
and γ-SM-actin in this muscle type, are arranged differently within the cytoplasm. βActin was found to be arranged in a more longitudinal direction and localized to dense
bodies, dense plaques, and in channels with intermediate filaments. Again, β-actin was
found to be closely associated with filamin, except at dense bodies, suggesting a
cytoskeletal role for β-actin. A number of studies have indicated that γ-actin, on the other
hand, is arranged more obliquely within the cytoplasm of the cells (Fay and Delise, 1973;
Small, 1974; Fisher and Bagby, 1977; Small et al., 1990). North et al. (1994) suggested a
model where γ-actin is not present in dense bodies, and therefore, it is not a component of
the cytoskeletal domain. However, they do not exclude the possibility that the γ-actin,
associated with myosin into contractile domains and running obliquely across the cell,
does not at some point cross through the cytoskeletal domains.
In other instances, actin isoforms have not been found to be compartmentalized
within cells, and in some cases, have been found to copolymerize with each other.
Experiments looking at the kinetics of polymerization of the various actin isoforms have
found that under physiological conditions there is little or no difference between the
polymerization of the various actin isoforms (Gordon et al., 1977; Mossakowska and
Strzelecka-Golaszewska, 1985; Umemoto and Sellers, 1990). Drew and co-workers
(Drew et al., 1991; Drew and Murphy, 1997) found that thin filaments in adult swine
stomach smooth muscle contained both smooth muscle actins and cytoplasmic actins
randomly distributed along the filaments. They could not rule out, however, that
individual filaments may have specific accessory proteins associated with them that may
dictate further the functioning of these filaments within the cell either as cytoskeletal or
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contractile filaments (Langanger et al., 1986). Song et al. (2000) also showed that
smooth muscle and nonmuscle actin isoforms are not separated into two populations of
thin filaments, but rather are copolymerized into the same filaments in smooth muscle
cells cultured from rabbit aorta. In this cell type, the two actin isoforms are α-SM-actin
and β-NM-actin. They did find, however, that the α-actin tended to make up the portion
of the actin filament found in the central region of the cell, while the β-actin tended to
form the portion of the same fiber found at the cell periphery. Either way, the
localization of the actin isoforms often times is similar to the expression of the actin
isoforms: tissue specific.
It is fairly obvious that if actin isoforms are separated into different compartments
or domains that they may perform different functions. For example, the work by North et
al. (1994), showed smooth muscle actins were arranged obliquely and associated with
myosin, and nonmuscle actins are arranged longitudinally and associated with filamin.
This clearly demonstrates that the actin associated with myosin is the actin involved in
the contraction of the cells, while suggesting the nonmuscle actin plays a structural role
typical of what would be seen of the cytoskeleton in nonmuscle cell types. However,
Khaitlina (2001) has cautioned that sorting of actin isoforms into different compartments
within the cell does not have to mean that they perform different functions but that they
could be performing the same functions in different regions of the cell.
On the other hand, Murphy (1992) suggested two criteria in determining if there
are functionally different roles for smooth muscle versus nonmuscle actins contained
within the same cell type. The first criteria is the presence of two distinct populations of
thin filaments characterized by the actin isoform composition of the filaments and
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possibly by the types of actin binding proteins associated with those filaments. The
second criteria is the separation of these two populations of actin filaments on the basis
that only the smooth muscle actins are associated with myosin. Throughout the
remainder of the dissertation, I try to satisfy these criteria and demonstrate that the actin
isoforms within A7r5 smooth muscle cells are two distinct populations with different
functions as well as different regulatory factors.
A7r5 Cell Line
The model utilized in this body of work is the A7r5 smooth muscle cell line. This
smooth muscle cell line was derived from embryonic rat aorta (Kimes and Brandt, 1976)
between days 14-17 gestation (Furulli et al., 1998). These cells do, however, exhibit a
phenotype much like that of adult smooth muscle cells. Furulli et al. (1998) examined
the expression of numerous markers specific to differentiated smooth muscle cells within
the A7r5 cell line. Among the markers they chose to study were smooth muscle myosin
heavy chain (one of the most specific markers for smooth muscle cells), smooth muscle
calponin, SM22, and smooth muscle α-actin. They found the A7r5 cell line expressed
transcripts for all of these smooth muscle cell markers. The A7r5 cell line retains these
marker proteins even after being maintained in cell culture conditions for prolonged
periods of time (Gimona, et al., 2003). This suggests the A7r5 cell line is a good model
for study of smooth muscle.
As mentioned previously, smooth muscle cells can have a range of phenotypes,
which can be determined partly by the actin isoform which is dominant. When cells
function primarily in contraction, there is a predominance of α-actin (Campbell and
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Campbell, 1993; Mosse, et al., 1985; Manderson, et al., 1989). As was mentioned in the
previous paragraph, smooth muscle α-actin is present within the A7r5 cells and is the
predominant actin isoform in this cell line.
Another important feature of the A7r5 cell line as a model for this work is its
ability to contract in response to various stimuli. The work presented here will look at
contraction of the A7r5 cells in response to phorbol 12, 13-dibutyrate, which will be
discussed in more detail in a later section. However, it has been found that cells of the
A7r5 cell line are also able to contract in response to other stimuli including vasopressin,
phenylephrin, and elevated potassium levels (Gimona et al., 2003).
A final feature about the A7r5 cell line that has made it an ideal model in this
body of work is its ability to be transfected. Furulli et al. (1998) examined four rat
smooth muscle cell lines: A7r5, adult and pup aortic, and PAC1. Among these four cell
lines, A7r5 was found to be the most highly transfected cell line of the four studied in
terms of the uptake of exogenous plasmid DNA. As will be seen in later chapters, the
transfection of the A7r5 cell line with plasmid containing β-actin DNA was a common
technique used to study the regulation and function of β-actin during phorbol contraction.
All of these points taken together indicate the A7r5 cell line is a good model for smooth
muscle research.
Smooth Muscle Contraction
The first step in smooth muscle contraction requires a stimulus to initiate
contraction. Such stimuli fall into one of two categories: electromechanical coupling or
pharmacomechanical coupling. In arterial smooth muscle, electromechanical coupling
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occurs through a change in the membrane potential of the cell either initiated by a
contractile agonist or by an increase in the extracellular concentration of potassium
([K+]o) (Rembold, 1996). Action potentials or an increase in [K+]o activate L-type
calcium channels allowing calcium to enter the cell, causing the intracellular calcium
concentration ([Ca2+]i) to rise (Hermsmeyer et al., 1988). Agonists such as
norepinephrine (Nelson et al., 1988; Haeusler and De Peyer, 1989; Neild and Koteca,
1987), histamine (Droogmans et al., 1977; Casteels and Suzuki, 1980; Keef and Bowen,
1989; Keef and Ross, 1986), and endothelin (McPherson and Angus, 1991) also can
cause depolarization of the smooth muscle membrane primarily through L-type calcium
channels or other voltage-gated calcium channels. In each of these instances, an increase
in [Ca2+]i occurs, which activates the cellular contractile machinery.
Pharmacomechanical coupling in arterial smooth muscle occurs when an agonist
causes the release of calcium from intracellular stores, when agonists activate either
voltage-dependent or voltage-independent calcium channels in the plasma membrane to
allow calcium to enter the cell (at a degree higher than expected with electromechanical
coupling), or when an agonist increases [Ca2+]i sensitivity (Rembold, 1996). In any of
these instances, an increase in [Ca2+]i or a change in the response to a given level of
[Ca2+]i may occur without a change in the membrane polarity of the cell (Rembold,
1996).
Once a stimulus has caused the [Ca2+]i to increase, the calcium binds to
calmodulin (Kretsinger and Nockolds, 1973). Calcium induces a conformational change
in calmodulin (Seamon, 1980) that allows it to interact with myosin light chain kinase
(MLCK) (Kamm and Stull, 1985; Walsh, 1994; Somlyo and Somlyo, 1994). The
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interaction of calcium-calmodulin with MLCK activates MLCK, allowing it to
phosphorylate the regulatory light chains of myosin at serine 19 (Adelstein and Conti,
1975; Gallagher et al., 1997). This step activates the actin-dependent ATPase activity of
myosin needed during cross-bridge cycling (Erdodi et al., 1996). The phosphorylation of
the regulatory light chains of myosin is the primary regulatory event leading to the
initiation of smooth muscle contraction (Ogut and Brozovich, 2003; Kamm and Stull,
1985).

Figure 1. Schematic of the biochemical events of smooth muscle contraction.
After phosphorylation of the regulatory light chains occurs, actin and myosin can
interact and begin cross-bridge cycling to develop tension and shorten the muscle cell. In
smooth muscle, it is thought that the phosphorylation of myosin allows the actin to bind
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to myosin, suggesting that this phosphorylation event is a regulatory step that occurs prior
to actin binding to myosin (Hartshorne and Gorecka, 1980). Once the actin has bound to
myosin, an inorganic phosphate (Pi) that is bound to the myosin from the previous crossbridge cycle is released, leaving an ADP bound to the actinomyosin complex. The ADP
is then released from the complex as well causing the myosin to pull the actin to generate
force and shortening. Once the ADP and Pi are released, an ATP molecule can bind to
the myosin of the actinomyosin complex. Once the ATP has bound, the actin is released
from the myosin. The ATPase of the myosin then hydrolyses the ATP into ADP and Pi
to initiate the cycle again.

Figure 2. Cross-bridge cycling of actin and myosin during muscle contraction. J.M.
Berg, J.L. Tymoczko, and L. Stryer. (2002). Biochemistry. New York: W. H. Freeman
and Company.
If phosphorylation of the regulatory light chains of myosin is a regulatory step to
allow cross-bridge attachment and cycling, then there must be a way to reverse this step
to cease cross-bridge cycling. The opposing enzyme to MLCK is myosin light chain
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phosphatase (MLCP), which removes the phosphate group from serine 19 of the
regulatory light chains of myosin (Alessi et al., 1992; Shimizu et al., 1994; Shirazi et al.,
1994). It is the balance of activities of MLCK and MLCP that determines to what degree
the regulatory light chains of myosin are phosphorylated (Erdodi et al., 1996).
In smooth muscle, however, contraction can be initiated and/or maintained
without phosphorylation of the regulatory light chains of myosin (Chatterjee et al., 1987;
Somylo et al., 1988; Adam et al., 1989; Katsuyama et al., 1992). Often times the
relationship between the amount of force developed and the degree to which the
regulatory light chains of myosin are phosphorylated depends on what initiates the
contraction or the length of time the muscle is contracted (Haeberle et al., 1985; Rembold
and Murphy, 1986; Jiang and Morgan, 1989; Laporte et al., 1994). One common theory,
known as the latch state, tries to explain how smooth muscle can remain tonically
contracted with the use of very little energy (Dillon and Murphy, 1982). This theory was
brought about by observations that even under circumstances where [Ca2+]i is low and the
level of myosin light chain phosphorylation is low, there can still be a substantial amount
of force maintained even with a reduction in cross-bridge cycling and ATP hydrolysis
(Siegman et al., 1984; Rembold and Murphy, 1986). In the context of this paper, the idea
that there are other means to initiate contraction without phosphorylation of the
regulatory light chains is of great importance and will be dealt with in more detail in later
sections.
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Phorbol Esters and PKC Isozymes
In the experiments we conducted, the A7r5 smooth muscle cell was contracted
with phorbol esters, specifically phorbol 12, 13-dibutyrate. Phorbol esters are derived
from the plant Croton tiglium, as well as from other plants belonging to the family
Euphorbiaceae (Hecker, 1968). Phorbol esters were originally utilized as tumor
promoters (Boutwell, 1974), but since then they have been found to have numerous other
roles, including the initiation of slow, sustained contractions in vascular smooth muscle
strips (Danthuluri and Deth, 1984; Rasmussen et al., 1984; Jiang and Morgan, 1987,
1989; Singer and Baker, 1987).

Figure 3. Structure of phorbol 12, 13-dibutyrate.

The mechanism by which phorbol esters work in the cell is by mimicking the
effects of diacylglycerol (DAG) (Kazanietz, 2005). DAG is a lipid second messenger
known to bind to protein kinase C (PKC) (Ron and Kazanietz, 1999). DAG is typically
generated in the cell through the interaction of a hormone or other extracellular effector
that binds to a receptor on the extracellular surface of the plasma membrane that is then
linked to the enzyme phospholipase C via a G-protein mediated process (Berridge, 1984;
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Majerus et al., 1986). Once phospholipase C is activated it cleaves phosphatidylinositol
4,5-bisphosphate to produce DAG and inositol 1,4,5-triphosphate (Blumberg, 1988).
DAG can then interact with PKC thereby activating it, as will be described in further
detail later. Phorbol esters mimick DAG by binding to the same site on PKC as DAG.
PKC was originally discovered in 1977 by Nishizuka and co-workers (Takai et
al., 1977). Ten isozymes of PKC have been found; each of which is a product of a
separate gene with exclusion of PKCβI and PKCβII, which are formed by alternative
splicing (for reviews see Mellor and Parker, 1998; Newton 1995, 1997). These 10
isozymes are divided into three subclasses based on the properties that regulate them.
The “conventional” or “classic” PKCs include the isozymes PKC α, βI, βII, and γ. This
subclass of isozymes is activated by calcium and/or DAG and phorbol esters. The second
subclass of isozymes is known as the “novel” PKCs. This subclass consists of the
isozymes PKC δ, ε, θ, and η. The novel PKCs are activated by DAG and phorbol esters
but not calcium. The last subclass is known as the “atypical” subclass of PKCs that
includes PKCζ and PKCι. This subclass of PKCs is not activated by either calcium or
DAG and phorbol esters. The isozymes of PKC that have been found in A7r5 cells
include PKCα (Kaplan-Albuquerque and Di Salvo, 1998; Fan and Byron, 2000), PKCβ,
and PKCγ (Fan and Byron, 2000). Evidence indicates that PKCα is the primary isozyme
involved in contraction in response to phorbol esters (Hai et al., 2002), which will be
discussed further in the next section.
Ron and Kazanietz (1999) reviewed the structure of the PKC isozymes. The
structure of the PKC isozymes consists of a single amino acid chain with two distinct
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domains joined by a hinge region. On the carboxy-terminal end is the kinase domain.
This domain consists of regions that interact with ATP and the specific substrates of the
isozyme. On the amino-terminal end of the protein is the regulatory domain. It is this
domain that varies most between the isozymes. The regulatory domain consists of
binding sites for DAG/phorbol esters and calcium, as well as regions that participate in
protein-protein interactions that help to regulate activation of PKC and its localization
within the cell.

Figure 4. Structure of the subclasses of PKCs. Modified from Ron and Kazanietz, 1999.

The C1 region of the regulatory domain is of particular interest to the topic of
phorbol esters binding to and activating PKC isozymes. The C1 region is a highly
conserved region among the PKC isozymes. This region consists of a pseudosubstrate
domain (autoinhibitory domain) and cysteine-rich domain(s). The pseudosubstrate
domain acts to keep the enzyme inactive by binding to the substrate binding site in the
catalytic domain when DAG/phorbol esters and/or calcium are not bound to the enzyme
(Orr et al., 1992). The pseudosubstrate domain can bind to the substrate binding domain,
because it resembles the substrates that would be able to bind to this site with exclusion
of a nonphosphorylated amino acid residue in place of the serine or threonine residue that
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the enzyme would typically phosphorylate (House and Kemp, 1987). The cysteine-rich
domains within the C1 region are the sites where DAG or phorbol esters bind in the
conventional and novel PKCs (Burns and Bell, 1991; Kazanietz et al., 1995a; Kazanietz
et al., 1995b; Ono et al., 1989).
There are three other highly conserved regions within the PKC isozymes. One of
these three is also in the regulatory region and is known as the C2 domain. The C2
domain is responsible for the binding of calcium in conventional PKC isozymes. There
is a C2-like domain within the regulatory region of novel PKC isozymes as well (Sossin
and Schwartz, 1993), but it does not play a role in calcium binding to these isozymes.
The other two highly conserved regions are within the catalytic domain of the isozymes
and are referred to as the C3 and C4 domains. The C3 domain contains the site for the
binding of ATP, while the C4 domain is the site for recognition and binding of the
substrate. It is the C4 domain to which the pseudosubstrate domain of the C1 region
binds to when the PKC isozyme is in its inactive form.
Phorbol esters have been found to bind to and activate conventional and novel
PKC isozymes. The manner in which they bind involves the presence of a phospholipid
cofactor, generally phosphotidylserine (Konig et al., 1985). It is important for the PKC
isozymes to be associated with phospholipids to regulate the translocation of PKC after
treatment with phorbol esters (Kazanietz, et al., 2000). Once the phorbol ester and
cofactor are bound, a conformational change occurs within the PKC isozyme resulting in
the removal of the pseudosubstrate domain of the C1 region from the binding site in the
C4 domain, which causes the activation of the PKC isozyme (Ron and Kazanietz, 1999).
It has been found that even under conditions where calcium and phosholipid cofactors are
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limited, phorbol esters still have the ability to activate PKC isozymes (Castagna et al.,
1982).
Initiation of Contraction by PKC
There is much debate on what role calcium plays in vascular smooth muscle
contraction in response to phorbol. Several investigators have found that treatment with
phorbol esters do cause an increase in [Ca2+]i leading to contraction of the smooth muscle
by means of MLCK, as discussed in the earlier section on smooth muscle contraction.
Others have found that phorbol esters can initiate contraction without an increase in
[Ca2+]i or phosphorylation of myosin light chain (Sybertz et al., 1986; Jiang and Morgan,
1987, 1989; Singer 1990). If myosin light chain is not phosphorylated, then phorbol
esters could initiate contraction by PKC phosphorylating other proteins that will result in
contraction (Walsh et al., 1994) or by increasing the sensitivity of the contractile
response to calcium so that contraction can occur at resting levels of intracellular calcium
(Jiang and Morgan, 1987).
Many studies have been conducted examining the role of calcium in contraction
of A7r5 cells in response to phorbol esters. There is conflicting evidence as to whether
there is an increase in intracellular calcium in the A7r5 cell line in response to phorbol
esters. In a study using A7r5 cells, Nakajima et al. (1993) proposed that the increase in
[Ca2+]i they found in response to phorbol esters appears to be caused by PKC modulating
calcium currents through voltage-dependent calcium channels (Fish et al., 1988). Sperti
and Collucci (1987) also reported an increase in the intracellular calcium in A7r5 cells in
response to treatment with phorbol diesters, which is blocked by dihydropyridines
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suggesting influx through voltage-dependent calcium channels. Rembold and Murphy
(1988) agreed with Sperti and Colluci with the added information that the effects of PDB
on intracellular calcium could be dependent on membrane potential of the cells. On the
other hand, Galizzi et al. (1987) found that treatment with phorbol esters of A7r5 smooth
muscle cells causes inhibition of calcium channel activity, suggesting calcium does not
play a role. Vigne et al. (1988) has shown that phorbol esters activate sodium-calcium
exchangers in A7r5 cells, which would cause a decrease in the intracellular levels of
calcium. Our laboratory (Li et al. 2001), has found that calcium appears to be necessary,
at least at low levels, to obtain the characteristic contraction and remodeling of α-actin in
response to PDBu.
In regards to increased sensitivity of the contractile response to calcium, Jiang and
Morgan (1987) showed results indicating that at resting levels of intracellular calcium,
phorbol esters can initiate contraction in rat and ferret aorta. These results confirm in
vitro studies indicating that phorbol esters and diacylglycerol increase the affinity of PKC
for calcium from the 1 X 10 -6 M range to the 1 X 10-7 M range, which falls within the
range of resting intracellular calcium concentrations (Nishizuka, 1986; Yamanishi et al.,
1983).
Addressing the last issue mentioned previously concerning other possible
substrates for PKC that could induce contraction in response to phorbol esters, there are
several that have been mentioned in the literature ranging from proteins previously
mentioned to be involved in smooth muscle contraction, such as MLCK, myosin light
chain, and myosin phosphatase, to other proteins that interact with the cytoskeleton, such
as caldesmon and calponin. While MLCK has been found to be a substrate for PKC in
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vitro (Ikebe et al., 1985; Nishikawa et al., 1985), it has been documented that
phosphorylation of MLCK by PKC does not have an effect on contractility (Stull et al.,
1990).
Myosin light chain has also been found to be an in vitro substrate of PKC (Bengur
et al., 1987; Ikebe et al., 1987). These in vitro studies indicated that PKC phosphorylates
myosin light chain at sites different from MLCK. PKC phosphorylates myosin light
chain at serine 1, serine 2, and threonine 9, while MLCK phosphorylates myosin light
chain at serine 18 and serine 19. Phosphorylation at PKC sites has been found to inhibit
actin-activated myosin Mg2+ ATPase activity and contraction (Bengur et al., 1987; Sutton
and Haeberle, 1990). There have been studies indicating that while myosin light chain is
phosphorylated at specific sites related to PKC, there is also a degree of phosphorylation
of myosin light chain that corresponds to the sites typically phosphorylated by MLCK
(Singer et al., 1989; Singer, 1990; Barany et al., 1992). It has been suggested that the
phosphorylation at the characteristic MLCK sites could be a result of inhibition of
myosin phosphatase (Masuo et al., 1994). The means by which this inhibition occurs is
by the phosphorylation of CPI-17 by PKC (Kitazawa et al., 1999).
There are two other possible substrates for PKC to interact with in the
cytoskeleton. One of these is caldesmon. Caldesmon is a protein that can cross-link
actin and myosin filaments (Ikebe and Reardon, 1988). Caldesmon functions to inhibit
actin-activated myosin Mg2+-ATPase activity (Ngai and Walsh, 1984). Phosphorylation
of caldesmon by PKC results in the release of actin thereby releasing the inhibition of the
actomyosin ATPase (Andrea and Walsh, 1992), which theoretically could lead to
contraction. It is thought that this interaction between caldesmon and PKC is not direct,
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but rather is a result of PKC acting on caldesmon via a cascade involving Ras, Raf,
mitogen-activated protein (MAP) kinase kinase, and MAP kinase (Adam and Hathaway,
1993).

Figure 5. Signal transduction pathway linking PKC to caldesmon (CaD) to initiate
contraction. (Walsh et al., 1994)

Calponin is the other possible PKC substrate found to interact with the
cytoskeleton (Winder and Walsh, 1993). Calponin also inhibits actin-activated myosin
Mg2+-ATPase activity by binding to actin (Winder and Walsh, 1990). PKC directly
phoshporylates calponin at serine 175 to release actin and the inhibition of the
actomyosin ATPase (Winder and Walsh, 1993, 1990), which has the potential to lead to
smooth muscle contraction.
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Podosomes
Podosomes were first reported in the mid-1980’s as structures that formed where
cells made contact when grown on an artificial surface (Marx, 2006). To date, no
podosomes have been reported to be found in vivo (Marx, 2006). Podosomes were first
described in cells that had been transformed by Rous sarcoma virus (David-Pfeuty and
Singer, 1980) and in cells derived from monocytes, such as osteoclasts (Marchisio et al.,
1984) and macrophages (Marchisio et al., 1987). Podosomes are generally 1-2 µm in
diameter (Marx, 2006) and are finger-like projections that extend up through the cell
from the ventral membrane, where the cell is in contact with the substrate, toward the
dorsal surface of the cell (Linder and Aepfelbacher, 2003). The core of the podosome
contains columns of actin filaments with proteins associated with actin polymerization,
such as N-WASp (Mizutani et al., 2002), Arp2/3 (Linder et al., 2000; Burns et al., 2001;
Kaverina et al., 2003), and cortactin (Schuuring et al., 1993, Ochoa et al., 2000; Pfaff and
Jurdic, 2001; Mizutani et al., 2002; Destaing et al., 2003). Surrounding the actin core is a
ring of proteins typically associated with focal adhesions, such as α-actinin and vinculin
(Marchisio et al., 1984; Tarone et al., 1985; Marchisio et al., 1988; Sobue et al., 1989;
Babb et al., 1997; Fultz et al., 2000; Hai et al., 2002; Destaing et al., 2003). The actin
core does not appear to be associated with the rest of the actin cytoskeleton (Gimona and
Buccione, 2006).
The function of podosomes is still a matter of debate. It is generally thought that
because they adhere to artificial substrates, podosomes play a role in cell adhesion and
cell motility (Marx 2006). In other instances, podosomes have been found to play a role
in remodeling of the cytoskeleton and matrix by controlling the localized turnover of
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cytoskeleton attachments and degradation of the extracellular matrix (Gimona and
Buccione, 2006).
Fultz et al. (2000) was the first to report the presence of podosomes in A7r5 cells
as a response to phorbol esters. However, he did not describe them as podosomes but as
peripheral bodies. It was Hai (2002) that first described these peripheral bodies as
podosomes. Fultz et al. (2000) found that cells stained with phalloidin and stimulated to
contract with PDBu developed discrete peripheral structures that were confirmed to result
from the remodeling of α-actin. The α-actin was found to disassemble from stress fibers
and reassemble into these peripheral structures resulting in the loss of most of the α-actin
stress fibers. A protein found to be associated with the actin core was α-actinin. Another
feature of the peripheral bodies was found to be that they extended vertically up from the
base of the cell.
Hai et al. (2002) confirmed the fact that the peripheral bodies arose from the base
of the PDBu treated cells, and they connected this to the defining feature of podosomes
(Nitsch et al., 1989; Wakino et al., 2001). They also found that vinculin, which is a
marker for focal adhesions, colocalized to the peripheral structures, suggesting that these
structures may arise from focal adhesions. As mentioned previously, podosomes have
been found to have both α-actinin (Fultz et al., 2000) and vinculin associated with the
actin core. The observations published in the work by Fultz et al. (2000) and the
observations made by Hai et al. (2002) led Hai to label the peripheral bodies as
podosomes.
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Numerous others have begun to study podosomes in A7r5 cells as well. Kaverina
et al. (2003) reported that the initiation and maintenance of podosomes in A7r5 cells
requires Arp2/3-dependent actin polymerization, which is consistent with findings about
podosomes in other cell types. They also found that the site of podosome formation
appears to be at the junction of actin stress fibers with focal adhesions. Work done by
Burgstaller and Gimona (2005) further indicated that podosomes in A7r5 cells are sites of
substrate degradation. Work continues in this area to define the structure and function of
these structures.
Myosin Light Chain Kinase
MLCK has already been mentioned as an enzyme involved in the regulation of
smooth muscle contraction by phosphorylating the regulatory light chain of myosin
thereby activating myosin ATPase (Aksoy et al., 1976; Chacko et al., 1977; DiSalvo et
al., 1978; Gorecka et al., 1976; Ikebe, et al., 1977; Sobieszek 1977). This section is
going to focus on the structure of the enzyme, and its role in binding to actin.
There are two genes responsible for expressing MLCK in vertebrates, but only
one gene is expressed in smooth muscle (Stull et al., 1986; Gallagher et al., 1997). The
other MLCK gene has been found to be expressed in striated muscle. MLCK is between
130-150 kDa depending on what species it is isolated from (Stull et al., 1998). The
catalytic site is found near the central region of the enzyme and is similar to other
serine/threonine protein kinases (Olson et al., 1990; Stull et al., 1986; Gallagher et al.,
1997). The C-terminal region is known as the telokin domain and is thought to be a site
for myosin binding (Ito et al., 1989). There are also two sites to which calmodulin binds
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to MLCK often referred to as the regulatory sites. One is found in the N-terminal region
of the enzyme between amino acids 26-41, and the other is found in the C-terminal region
between amino acids 787-815 (Olson et al., 1990; Ye et al., 1997; Gao et al., 2001). The
calmodulin binding site in the C-terminal region acts to regulate the kinase activity of
MLCK (Olson et al., 1990). The calmodulin binding site in the N-terminal region acts to
regulate the actin binding activity of MLCK (Ye et al., 1997). MLCK also has two actin
binding domains within the N-terminal region of the enzyme (Ye et al., 1997). One of
the actin binding domains is within amino acids 1-41, while the other is within amino
acids 138-218 (Ye et al., 1997; Gao et al., 2001). Notice that one of the actin binding
sites overlaps with one of the calmodulin binding sites. This particular actin binding site
is referred to as a Ca2+/CaM sensitive binding site. Binding of Ca2+/CaM to this site
causes MLCK to release actin from this binding site (Ye et al., 1997). The other actin
binding site is referred to as a Ca2+/CaM insensitive binding site (Ye et al., 1997).

Figure 6. Schematic structure of MLCK. Redrawn from Molecular Mechanisms of
Smooth Muscle Contraction, Chapter 2, Hayakawa et al., 1999. The red, blue, and green
color regions indicate the location of the binding of listed molecules to MLCK.
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MLCK has been found to bundle actin filaments by cross-linking actin filaments
between the Ca2+/CaM sensitive and insensitive actin binding sites found within the Nterminal region of MLCK (Hayakawa et al., 1994, 1999; Gao et al., 2001). When MLCK
bundles actin filaments, it also causes an inhibitory effect on the interaction of actin
and myosin. This inhibition is relieved in the presence of Ca2+/CaM (Kohama et al.,
1992). Hayakawa et al. (1999) concluded the bundling activity of MLCK with actin is
too low to possess any physiological relevance without the interaction of an additional
protein yet to be identified.

Summary
Taken together, the literature indicates that smooth muscle contraction has a
unique way of developing force that cannot be solely explained on the basis of the
classical actin/myosin sliding filament theory, even though some of the concepts may
apply to smooth muscle. Our laboratory and others have proposed that in smooth muscle
the actin cytoskeleton undergoes dynamic remodeling during force development. This
remodeling is important to maintain actin and myosin at optimal opposition to enhance
force development and to allow for slow, sustained force development, a unique
characteristic of smooth muscle contraction.
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Abstract
In the present study, we investigated the reorganization of α- and β-actin in the
contracting A7r5 smooth muscle cell. The remodeling of these actin variants was
markedly different in response to increasing concentrations of phorbol 12, 13-dibutyrate
(PDBu). At the lowest concentrations (≤ 10-7 mol/L), cells showed an ~70% loss in αactin stress fibers with robust transport of this isoform to podosomes. By comparison, βactin remained in stress fibers in cells stimulated at low concentrations ≤( 10

-7

mol/L) of

PDBu. However, at high concentrations (≥ 10-6 mol/L) ~50% of cells showed transport
of β-actin to podosomes. Consistent with these findings, staining with phalloidin
indicated a significant decrease in the whole-cell content of F-actin with PDBu treatment.
However, staining with DNase I indicated no change in the cellular content of G-actin,
suggesting reduced access of phalloidin to tightly packed actin in the podosome core.
Inhibition of protein kinase C (staurosporine, bisindolymaleimide) blocked PDBuinduced (5 x 10-8 mol/L) loss in α-actin stress fibers or reversed podosome formation
with re-establishment of α-actin stress fibers. By comparison, these inhibitors caused
partial loss of β-actin stress fibers. The results support our earlier conclusion of
independent remodeling of α- and β-actin cytoskeletal structure and suggest that the
regulation of these structures is different.
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Introduction
Several isoforms of actin have been isolated from eukaryotic cells that, based on
their motility in isoelectric focusing, have been classified as α-, β-, and γ-actins.
Sequence analysis has indicated that actin structure is highly conserved with only minor
heterogeneity (<10%) among isoforms (Khaitlina 2001). Nevertheless, there is clear
evidence for tissue specificity of actin isoform expression. Four isoforms of actin have
been identified in mammalian and avian smooth muscle: α- and γ-smooth muscle and βand γ-nonmuscle or cytoplasmic actin. The β-actin isoform has been found in all smooth
muscle tissue examined thus far, whereas, the expression of the remaining isoforms is
tissue-specific (Hartshorne 1987). The γ-actin isoform is found in visceral smooth
muscle (Hartshorne 1987; North et al. 1994; Toullec et al. 1991), whereas α-actin is the
predominant muscle actin isoform in vascular smooth muscle (Fatigati and Murphy 1984;
Hartshorne 1987). The expression of multiple actin species within a single cell type
suggests that the isoforms serve different functions. Consistent with this idea, actin
isoform compartmentalization has been reported in a variety of cell types (Khaitlina
2001). Based on immunohistochemistry and the distribution of actin-associated proteins,
it was proposed early on that smooth muscle cell actins could be separated into
contractile and cytoplasmic domains containing smooth muscle-specific and nonmuscle
isoforms, respectively (DeNofrio et al. 1989; Herman 1993; North et al. 1994; Small
1995). However, other investigators have challenged the spatial separation of actin
isoforms in smooth muscle. Drew and Murphy (1997) reported that actin filaments
isolated from swine stomach fundus consisted of copolymerized muscle and nonmuscle
actins at about the same composition ratio of tissue homogenates. Stromer et al. (2002)
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showed localization of β-actin, α-, and (or) α/γ-actin and α-actinin at discrete cellular
and membrane foci, confirming that both muscle and nonmuscle filaments are associated
with cell dense bodies and plaques in several types of smooth muscle. Based on their
observation of low level staining for β-actin throughout filament structure, however, they
concluded that there was extensive overlap of muscle-specific and nonmuscle isoforms,
arguing against spatial separation into contractile and cytoplasmic domains. By
comparison, Song et al. (2000) showed a distinctly herterogenous distribution of actin
isoforms in cultured smooth muscle cells. They noted a predominate localization of βactin at the cell periphery associated with vinculin plaques, striated myosin, and α-actinin
aggregates, whereas α-actin was observed in the central region of the cell associated with
continuous myosin and punctate α-actinin staining. However, they further showed an
apparent transition in composition of individual stress fibers from β-actin to α-actin from
periphery to cell center, indicating incomplete separation into discrete domains.
Taken together, these studies suggest at least partial segregation of smooth
muscle-specific and nonmuscle actin isoforms. This, in turn, suggests that, despite the
high level of homology, mechanisms are available for sorting actin isoforms. Consistent
with this conclusion, Mounier et al. (1997) have reported direct evidence of differentiated
sorting of labeled actin isoforms introduced into smooth muscle and nonmuscle cells. In
addition to evidence of spatial segregation, several studies have suggested that α- and βactin organization may be governed by different mechanisms and could serve different
functional roles in the contractile and motility properties of fibroblasts and smooth
muscle cells. For example, experimental manipulation of α- and β-actin structure and
expression levels has been shown to selectively alter contraction and cell motility,

44

respectively (Hinz et al. 2001; Ronnov-Jessen and Petersen 1996; Schedlich et al. 1997).
Recent evidence has further indicated that the introduction of the NH2-terminal sequence
of α-actin into myofibroblasts inhibits contractile activity, whereas the NH2-terminal
peptide of β-actin had no effect (Hinz et al. 2002).
Our laboratory has reported that the reorganization of α- and β-stress fibers is
different during phorbol ester-induced contraction of A7r5 cells (Fultz et al. 2000; Li et
al. 2001a). During the interval of cell contraction, β-actin fibers remained stable,
whereas α-actin reformed into intensely fluorescing peripheral bodies that have been
subsequently identified as podosomes (Hai et al. 2002), suggesting the isoforms were
subject to different regulatory control. Gimona et al. (2003) have recently reported that
actin stress fibers decorated with h1-calponin remained stable, whereas those associated
with SM22 were transported to podosomes in PDBu-treated A7r5 cells, suggesting 2
functionally distinct actin filament populations. However, in contrast to our earlier
observations, they found that β-actin as well as α-actin was localized at podosomes. One
possible explanation of results was the difference in concentrations of PDBu used to
stimulate cells in the 2 studies. In the present study we examined the remodeling of αand β-actin in response to a range of PDBu concentrations as well as comparing the
effects of contractile antagonists on their organization during PDBu stimulation. The
results support earlier conclusions of spatial and regulatory segregation of α- and β-actin
in the A7r5 cell.
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Materials and Methods
Cell Culture
A7r5 smooth muscle cells, derived from embryonic rat aorta and shown to
maintain the ability to contract to phorbol esters (Fultz et al. 2000; Nakajima et al. 1993),
were obtained from American Type Culture Collection (Manasass, Va.). Cells were
plated on 75-cm2 flasks and grown to approximately 85% confluence at 37oC in a
humidified atmosphere of 5% CO2 in air. The cells were maintained in Dulbecco’s
modified Eagles medium (DMEM) supplemented with 10% fetal bovine serum, 100
U/mL penicillin G, and 100 µg/mL streptomycin. Media was changed every other day
and cells were passaged at least once a week. Passaging was accomplished by addition of
trypsin-EDTA solution in PBS and collection of cells by centrifugation.

Confocal Microscopy
In experiments employing immunostaining, cells were seeded onto glass
coverslips, placed in 6-well culture plates and returned to the incubator for a minimum of
24 h to allow for attachment and spreading. After experimental treatment, cells were
fixed and permeabilized by addition of ice cold acetone for 1 min. The cells were
washed several times with PBS containing 0.5% Tween-20 (PBS-T), pH 7.5, followed by
a 30-min incubation in blocking solution containing 5% nonfat dry milk in PBS. α-Actin
staining was accomplished by incubation of cells in a 1:500 dilution of monoclonal-αsmooth muscle actin, clone 1A4 FITC-labeled antibody (Sigma Chemical Co., St. Louis,
Mo.) for 60 min at room temperature. β-Actin was imaged using a 1:500 dilution of
monoclonal anti-β-actin, clone AC-15 primary antibody (Sigma) followed by incubation
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with an Alexa 488 labeled secondary antibody (Molecular Probes, Eugene, Ore.). Cells
were imaged by mounting on a Nikon Diaphot Microscope and confocal microscopy
performed with a Bio-Rad Model 1024 scanning system with a Krypton/Argon laser.
Micrographs were constructed by projection of Z-plane acquisitions and analyzed by
Lasersharp and Confocal Assistant Software (BioRad, Hercules, Calif.). The ratio of
cellular filamentous (F-actin) to monomeric (G-actin) actin was estimated using dual
staining with phalloidin and DNase I by a modification of the method of Knowles and
McCulloch (1992). Cells were fixed with ice-cold acetone for 1 min, rinsed with PBS
(3X) and then incubated with Alexa Fluor-DNase I and Alexa Fluor-phalloidin
(Molecular Probes, Eugene, Ore.) for 1 h. Cells were thoroughly rinsed with PBS and
embedded in Gel-Mount media (Fischer, Chicago, Ill.) on glass slides. Cells were then
visualized using a Bio-Rad 1024 scanning confocal microscope with laser settings kept
constant for all experimental groups. Nuclear fluorescence was eliminated using Paint
Shop Pro. Whole-cell pixel counts were obtained by boxing cells using the rectangular
tool with ImageJ program (NIH, Bethesda, Md.). F-actin to G-actin ratios were
calculated by dividing pixel counts obtained for phalloidin and DNase I staining,
respectively, for each cell. Because 20% to 30% of cells do not respond to PDBu, cells
showing robust podosome formation were selected for evaluation.

Cell treatments and analysis of actin remodeling
PKC inhibitors staurosporine and bisindolymaleimide were added at a final
concentration of 10x the reported IC50 or Ki value. The effect of the compounds were
evaluated in their ability to alter α-actin and β-actin structure both during PDBu-
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stimulated (5 x 10-8 mol/L) reorganization and after PBDu-induced reorganization was
established. For the former experiments, an inhibitor was added 30 min before PDBu
with the cells fixed for imaging 30 min after PDBu stimulation. For the latter, the
inhibitor was added 30 min following PDBu with cells fixed for imaging at 30 min after
the introduction of inhibitor. Vehicle-control cells were fixed at identical intervals as the
inhibitor-treated cells.
Based on the work of Chrzanowska-Wodnicka and Burridge (1996) showing that
internal strain on the cytoskeleton was required for formation of stress fibers, we assumed
that contractile antagonists would result in significant loss of tension bearing structures.
Consequently, in addition to qualitative assessment of actin stress fibers (fiber breakage,
compression), an attempt was made to obtain quantitative information concerning loss of
structure. Surprisingly, the contractile antagonists did not result in loss of α-actin stress
fibers. Rather, the protein kinase inhibitors blocked α-actin stress fiber remodeling to
podosomes when added before PDBu and caused a reversal of podosome formation with
reformation of stress fibers when added after PDBu. Therefore, counts of cells exhibiting
podosome formation were used as a measure of inhibitor effect on α-actin remodeling.
Cell counts were performed in 3 separate experiments with a total of approximately 300
cells counted per experiment. Cells were scored by 2 viewers and the counts were
averaged.
In contrast to α-actin, inhibitors caused noticeable loss in β-actin structure. To
estimate losses in β-actin stress fibers, confocal images of treated and control cells were
obtained at fixed confocal settings and analyzed using Image J software (NIH). Using
the line scan tool, the cell was bisected in the long axis at mid-cell and the resulting plot
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was imported into Microsoft Office Excel (Fig. 1). The point of lowest intensity was
selected as baseline and the graph was then analyzed using Peakfit 4.0 software to
determine the area under the curve (I = total intensity). This value was then divided by
line pixel number (p) to normalize for line length. The final value, β-actin filament
intensity = I/p was calculated using Excel.
Western blot analysis
A7r5 cells were plated on 150 mm x 25 mm tissue culture dishes and grown to
approximately 85% confluence as described in the cell culture section. Cells were treated
with vehicle (Control) or 10-7 mol/L PDBu for 30 min to allow cells to contract. After
contraction, control and PDBu treated cells were collected by addition of trypsin-EDTA
and centrifugation. Cells were resuspended in 300 µL RIPA lysis buffer containing
Complete protease inhibitor cocktail tablet (Roche Diagnostics, Indianapolis, Ind.) for 30
min on ice. To separate G-actin from F-actin, the cell lysates were centrifuged at
100,000g for 1 h at 4oC. Upon completion of centrifugation, the supernatant was
removed for analysis of G-actin. An amount of lysis buffer equal to the supernatant was
added to the pellet and allowed to soften on ice for 1 h. The pellet was then resuspended
and sonicated for analysis of F-actin. Concentration of total protein per sample tube was
determined using BCA (Pierce) protein assay. Samples were denatured in SDS sample
buffer and subjected to 12.5% SDS-PAGE. Protein was transferred to PVDF membrane
(Pierce) using a Fischer Biotech semi-dry blotting unit. Blots were blocked for 1 h with
5% nonfat dry milk in PBS followed by washing 3 times for 5 min each. The blot was
then probed with a 1:500 dilution of monoclonal-anti-actin, α-smooth muscle primary
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antibody (Sigma, St. Louis, Mo.) for 1 h followed by washing. The blot was then
incubated for 1 h with anti-mouse Ig, horseradish peroxidase-linked secondary antibody
(Amersham Biosciences, Piscataway, N.J.) followed by washing. Horseradish peroxidase
activity was detected using the ECL Western Blotting Detection system (Amersham
Bioscience).
Data analysis
Analysis of differences between treatment means was performed by 1-way
ANOVA followed by Student’s unpaired t test (Sigma Stat, SPSS, Chicago, Ill.).
Differences between means were considered significant if p ≤ 0.05. Averaged results are
presented as mean ± SE throughout the text.
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Results
Actin concentration response to PDBu
There was a marked dichotomy in the concentration-response of PDBu-stimulated
α- and β-actin reorganization into podosomes (Table 1; Fig. 2). A total of 40% to 70% of
cells stained for α-actin showed robust podosome formation with an approximate 70%
loss in stress fibers (Table 1) at the lowest PDBu concentrations (10-8 mol/L and 10 -7
mol/L). In contrast, few cells imaged for β-actin showed evidence for podosome
formation (Fig. 2) and loss of stress fibers (Table 1) at lower PDBu concentrations.
However, approximately 50% of these cells exhibited formation of these structures at
PDBu concentrations ≥ 10-6 mol/L (Fig. 2).
Dual staining of control cells with phalloidin and DNase I indicated F-actin
incorporation into stress fibers (Fig. 3A) with G-actin diffusely distributed within the cell
body (Fig. 3B). Contraction of the cell with 10 -7 mol/L PDBu resulted in an apparent loss
in stress fibers with translocation of F-actin to podosomes (Fig. 3C), a pattern of
reorganization that appeared to be intensified in cells treated with 10 -5 mol/L PDBu (Fig.
3E). Interestingly, there was a clear redistribution of G-actin to the cell periphery with
PDBu treatment (Fig. 3D, 3F). Particularly in cells contracted with 10-5 mol/L PDBu, Gactin appeared to diffusely distribute about the F-actin-containing core of podosomes. As
expected from visual evaluation of images, simultaneous staining with phalloidin and
DNase I indicated a significant reduction in the ratio of F-actin to G-actin in PDButreated cells (Table 2). However, this change was due to a decrease in F-actin
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fluorescence with no evidence of significant alteration in the cellular content of G-actin.
This suggests that PDBu stimulation did not result in a net depolymerization of actin but
that the balance of actin from stress fibers was incorporated as tightly packed filaments in
the core of podosomes. Consistent with this idea, Western blot analysis indicated no
change in the content of F- and G-α-actin in PDBu-treated compared with control cells
(Fig. 4).
Effects of protein kinase inhibitors on actin structure
Figure 5 shows the distribution of α- and β-actin in unstimulated and PDButreated (5 x 10-8 mol/L) A7r5 control cells. In the resting cell, both isoforms are
incorporated into stress fibers arranged in parallel. During PDBu-induced contraction,
the 2 actins undergo distinct modes of reorganization. As the cell contracts, α-actin
structure exhibits a loss (~70%) in stress fibers (Table 1) with the formation of
podosomes. By comparison, β-actin stress fibers shorten in the interval following PDBu
(Fig. 5) without loss in structure (Table 1). The introduction of PKC inhibitors prior to
PDBu resulted in variable effects on α-actin structure (Table 3A; Fig. 6). Both
staurosporine and bisindolymaleimide blocked α-actin remodeling to podosomes.
However, these cells showed well developed α-actin stress fibers suggesting sufficient
strain on filaments to maintain these structures and their anchorage sites at focal
adhesions. Staurosporine but not bisindolymaleimide caused significant losses in β-actin
stress fibers (Table 3B; Fig. 6) when added prior to PDBu. The addition of PKC
inhibitors after PDBu addition and the establishment of actin reorganization resulted in
the reversal of podosome formation and re-establishment of an extensive system of α-
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actin stress fibers (Table 3A; Fig. 7). By comparison, inhibitor treatment of cells after
PDBu stimulation resulted in highly significant losses in β-actin stress fibers (Table 3B;
Fig. 7).
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Fig. 1. Quantitative assessment of actin filament structure loss. Images of
(A) control and (C) inhibitor-treated cells were obtained at fixed confocal
settings and analyzed using Image J software. Each cell was bisected in
the long axis by line scan and the resulting plot (B, D) imported to
Microsoft Office Excel. The graph was analyzed by Peakfit 4.0 software to
obtain the area under the curve (I = total intensity) that was divided by line
pixel number (p) to normalize for cell width. The final number, filament
intensity = I/p, was calculated in Excel.
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Fig. 2. The concentration-response of α- and β-actin remodeling to PDBu. (A)
Images of cells showing α-actin and β-actin structure after 30 min incubation at 10-8
or 10-5 mol/L PDBu. α-Actin was imaged using a monoclonal α-smooth muscle
actin, clone 14C FITC-labeled antibody. β-Actin was imaged by use of a
monoclonal anti-β-actin, clone AC-15 primary antibody followed by an Alexa 488labeled secondary antibody. (B) Graphical presentation of the percentage of cells
imaged for α- or β-actin that exhibited podosome formation at increasing
concentrations of PDBu. The results indicate a significant difference in the response
of the 2 isoforms. α-Actin showed robust localization at podosomes even at the
lowest concentration studied. By comparison, β-actin remained in stress fibers and
was transported to podosomes only at high (≥10-6 mol/L) concentrations of PDBu.
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Fig. 3. Visualization of F-actin and G-actin in control (unstimulated) and
PDBu-stimulated (5 x 10-8 mol/L) A7r5 cells. Cells were fixed with acetone
and then stained with Alexa Fluor-Phalloidin and Alexa Fluor-DNase I for
imaging with a Bio-Rad 1024 scanning confocal microscope. The images are
typical of cells showing F-actin translocation from stress fibers to podosomes
with redistribution of G-actin to the periphery about the podosomes after PDBu
treatment. Bar represents 50 µm.
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Fig. 4. Western blot analysis of monomeric (G-actin) and
filamentous (F-actin) α-actin in unstimulated (control) and
PDBu-treated A7r5 cells. Cells were lysed and, following
centrifugation, protein from the pellet and supernatant
were separated on 12.5% SDS-PAGE. Blots were probed
with monoclonal anti-actin α-smooth muscle primary
antibody followed by anti-mouse, horseradish peroxidaselinked secondary antibody. Values were calculated as
percent of total α-actin protein. Bars indicate the average
of 6 independent experiments.
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Fig. 5. The reorganization of α- and β-actin in unstimulated and PDBu (5
x 10 -8 mol/L) stimulated control cells. Cells were stained with FITClabeled phalloidin, monoclonal α-smooth muscle actin, clone 14A FITClabeled antibody, or a monoclonal anti-β-actin, clone AC-15 primary
antibody followed by an Alexa 488-labeled secondary antibody. The
results demonstrate the loss in stress fibers and localization of α-actin at
podosomes. By comparison, β-actin is retained in stress fibers that shorten.
Bar represents 50 µm.
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Figure 6
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Fig. 6. Changes in α- and β-actin structure resulting from the addition of
PKC inhibitors, staurosporine and bisindolymaleimide, 30 min prior to PDBu
(5 x 10-8 mol/L) stimulation. α-Actin was imaged using a monoclonal αsmooth muscle actin, clone 14A FITC-labeled antibody. β-actin was imaged
using a monoclonal anti-β-actin, clone AC-15 primary antibody followed by
an Alexa 488-labeled secondary antibody. Inhibitors or vehicle was added
30 min prior to PDBu and the cells were fixed for staining 30 min after
PDBu. The results indicate that inhibitors blocked PDBu-induced losses in
α-actin stress fibers and formation of podosomes. By comparison,
staurosporine caused a significant loss in β-actin structure. Bar represents 50
µm.
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Figure 7
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Fig. 7. Changes in α- and β-actin structure resulting from the addition of PKC
inhibitors, staurosporine and bisindolymaleimide, after stimulation of cells with
5 x 10-8 mol/L PDBu and the formation of podosomes. Inhibitors were added 30
min after PDBu and cells were fixed for staining 30 min after inhibitor addition.
α-Actin was imaged using a monoclonal α-smooth muscle actin, clone 14A
FITC-labeled antibody. β-Actin was imaged using a monoclonal anti-β-actin,
AC-15 primary antibody followed by an Alexa 488-labeled secondary antibody.
The results indicate that inhibitors reversed podosome formation with reestablishment of α-actin stress fiber structure. By comparison, both inhibitors
caused significant losses in β-actin stress fiber structure. Bar represents 50 µm.
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Table 1. Comparison of α-actin vs. β-actin filamentous structure in the
A7r5 cell.
α-Actin

β-Actin

Control

147.7 ± 12.1

73.0 ± 3.1

PDBu

43.8 ± 5.7*

77.5 ± 4.5

-70.4

+6.1

% Change

Note: Confocal microscopy line scan analysis of actin filamentous
structure in control and PDBu-stimulated (5 x 10-8 mol/L) cells.
Results are presented as fluorescence intensity/pixel number (I/p). A
minimum of 10 cells were evaluated in each group. *p ≤ 0.05 vs.
control.
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Table 2. The ratio of cellular F-actin to G-actin obtained from whole
cell fluorescence intensity measurements of A7r5 cells simultaneously
stained with phalloidin (F-actin) and DNase I (G-actin).
F-Actin

G-Actin

Ratio (F/G)

Control

100.0 ± 6.5

100.0 ± 8.4

1.68 ± 0.12

PDBu (10-7 mol/L)

55.1 ± 4.1*

85.9 ± 11.2

1.08 ± 0.05*

PDBu (10-5 mol/L)

74.5 ± 5.0*

106.1 ± 9.4

1.11 ± 0.04*

Note: Prior to fixation for staining, cells were unstimulated (control) or
were contracted by addition of 10-7 mol/L or 10 -5 mol/L phorbol 12, 13dibutyrate (PDBu). Only those PDBu-treated cells showing robust
podosome formation were selected for evaluation. A minimum of 6 cells
were studied in each group. F- and G-actin values are presented as
percent of control. Ratios were calculated by dividing pixel counts from
phalloidin fluorescence measurements by those from DNase I
measurements. *p < 0.05 vs. control.
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Table 3. A comparison of the effects of protein kinase C
(staurosporine, bisindolymaleimide) inhibitors on PDBu-induced
reorganization of α- and β-actin in A7r5 cells.
Inhibitor

Before PDBu

After PDBu

Staurosporine

30.2 ± 2.0*

9.1 ± 3.1*†

Bisindolymaleimide

4.3 ± 1.6*

12.2 ± 3.3*

Pooled Control

100.0 ± 3.5

100.0 ± 2.8

Staurosporine

71.1 ± 5.4*

74.6 ± 7.3*

Bisindolymaleimide

91.4 ± 2.8

74.5 ± 4.2*

Pooled Control

100.0 ± 5.8

100.0 ± 4.3

(A) α-Actin

(B) β-Actin

Note: Inhibitors were added 30 min before stimulation with PDBu (5
x 10-8 mol/L) to evaluate their effect on active cytoskeletal
remodeling or 30 min after PDBu to evaluate their effect on PDBuinduced changes in remodeled structure. Results for α-actin are
based on cell counts indicating the percent of cells showing PDBustimulated podosome formation. Results for β-actin are based on cell
line scans measuring fluorescence intensity as an index of β-actin
stress fiber structure. In each case, values are expressed as percent of
values obtained from PDBu-stimulated inhibitor vehicle controls. *p
< 0.05 vs. control, † p < 0.05 before vs. after PDBu.
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Discussion
In previous work, we showed that the reorganization of the 2 major isoforms of
actin was markedly different in response to low concentration (10-8 mol/L) phorbol ester
stimulation and contraction in A7r5 smooth muscle cells (Fultz et al. 2000). α-Actin was
observed to reform from stress fibers into peripheral bodies now identified as podosomes
(Hai et al. 2002), whereas β-actin remained in stress fibers that shortened during the
contraction of the cell. Differences in the modes of actin isoform remodeling could be
important for implications regarding regulatory control and function in smooth muscle.
However, a more recent report (Gimona et al. 2003) has demonstrated that at high
phorbol ester concentration, β-actin also localizes at podosomes. The present results
confirm these previous findings and further indicate a marked dichotomy in the
concentration-response of actin isoform reorganization to PDBu. α-Actin showed robust
podosome formation with a maximum in the percentage of cells exhibiting these
structures observed at 10-7 mol/L PDBu. By comparison, PDBu concentrations at 10-6
mol/L or greater were required for similarly robust relocation of β-actin at podosomes
(Fig. 2). We suggest 2 possible explanations of these results. Evidence has been reported
suggesting that podosome formation is mediated through activation of PKCα (Gatesman
et al. 2004). It has been further shown that PKCα exhibits a PDBu concentrationdependent translocation either to the subplasmalemma (10-7 mol/L) or to the perinuclear
region (>10-7 mol/L) in A7r5 cells (Li et al. 2001b). Hence, differences in PDBu
concentration-dependent localization of actin isoforms could reflect differences in the
localization of the regulatory machinery controlling α- and β-actin structure.
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Alternatively, increasing concentrations of PDBu could result in a higher level of
PKC activation or the activation of additional regulatory pathways. PDBu has been
shown to bind and activate conventional and novel PKC isozymes with high affinity (Kd,
10-9 mol/L) (Kazanietz et al. 1993) that leaves little reason to believe that concentrations
ranging at 10-6 mol/L would be required for full activation of the enzyme. Moreover, our
work has shown that cells stimulated at 10-8 mol/L PDBu may contract profoundly, with
shortening of β-actin fibers to the point that the resolution of individual fibers is lost in
the absence of β-actin localization at podosomes (Fultz et al. 2000). On the other hand,
there is substantial evidence that phorbol esters at high concentration may utilize other
receptors than PKC (Kazanietz 2000) and activate PKC-independent pathways (Rapuano
and Bockman 1997). Hence, whereas the physiological significance of biological
responses at high concentrations of phorbol ester is uncertain, the results raise the
interesting possibility that α- and β-actin contractile remodeling is regulated by different
pathways.
Consistent with previous observations of PDBu-induced stress fiber loss,
quantification of whole cell fluorescence in cells simultaneously stained with phalloidin
(F-actin) and DNase I (G-actin) indicated a significant decrease in the ratio of
filamentous to monomeric actin in PDBu-treated cells (Table 2). However, this change
occurred without significant increases in G-actin, suggesting there was no net
depolymerization of actin despite the obvious loss of stress fibers in these cells. A
possible explanation is the net incorporation of stress fiber actin into the tightly packed
filaments forming the podosome core (Gimona et al. 2003), which would be expected to
stain less completely than stress fibers. Consistent with this idea, Western blot analysis
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indicated effectively identical F-actin content in PDBu-treated (76.7% ± 2.2%) compared
with unstimulated control cells (80.0% ± 3.2%). How such a translocation of actin to
podosomes occurs is not certain. Verkhovsky et al. (1997) has described actin polarity
sorting with direct translocation of filaments to podosome-like structures in contracted
fibroblasts. However, more recent evidence suggests that podosome formation is
initiated by de novo actin polymerization at the stress fiber/focal adhesion interface
(Kaverina et al. 2003). Interestingly, we observed the redistribution of G-actin to the
periphery and about the podosomes in PDBu-treated cells (Fig. 3). A likely explanation
of this pattern of localization is that the podosomes are focal points for high rates of actin
filament turnover. Because of evidence suggesting that phorbol-induced podosome
formation is mediated by PKC (Gatesman et al. 2004; Hai et al. 2002), we investigated
the effects of selected protein kinase inhibitors on α- and β-actin structure when added
either before or after 10-7 mol/L PDBu. Two PKC inhibitors were studied:
staurosporine, an inhibitor of PKC (Chabannes et al. 2001; Matsumoto and Sasaki 1989)
that may affect various serine/threonine kinases at high concentration (Peet and Li 1999)
and bisindolymaleimide I, a selective inhibitor of PKC (Toullec et al. 1991). Both
staurosporine and bisindolymaleimide have been shown to suppress force development in
smooth muscle (Wright and Hurn 1994; Yamamoto et al. 1995; Yang et al. 2001).
Inhibition of PKC blocked or reversed α-actin localization at podosomes leaving stress
fibers intact (Table 3A), which is consistent with a direct role of PKC in destabilization
of stress fibers and the stabilization of podosome formation. Unlike the effect of the
inhibitors to stabilize α-actin stress fibers, these compounds caused detectable losses in
β-actin stress fibers (Table 3B), particularly when added after PDBu stimulation. This
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suggests that PKC contributes, at least in part, to the stability of β-actin stress fiber
structure during PDBu stimulation.
In summary, lack of similarity in the organizational response of α- and β-actin to
different concentrations of PDBu or the introduction of protein kinase inhibitors indicates
these isoforms could be subject to different regulatory influences. In turn, this raises the
possibility that the 2 isoforms could serve different functions in the contracting smooth
muscle cells. In the present study we demonstrate reversal of podosome formation and
re-establishment of α-actin stress fibers with partial loss of β-actin stress fiber structure
in the presence of PKC inhibitors. These results suggest that the destabilization of stress
fibers and transport and (or) maintenance of α-actin at podosomes is actively regulated
by PKC. In contrast, the stability of β-actin stress fiber structure is at least partially
dependent on PKC activity during PDBu-induced cytoskeletal remodeling.
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Abstract
Previous work in our laboratory has suggested a role for myosin light chain kinase
in the crosslinking of actin filaments (Thatcher et al., 2007). This role for MLCK was
attributed to non-kinase domains within the protein. However, the possibility remained
that the kinase activity of MLCK and the resulting tension generated in tension bearing
structures within the cell could contribute directly to the remodeling of the cytoskeleton
during contraction. In the present study, we investigated the role of the kinase domain of
MLCK in the crosslinking of actin filaments. Experiments were conducted using two
inhibitors of the kinase domain of MLCK, ML-7 and ML-9, added prior to phorbol 12,
13-dibutyrate (PDBu) and after PDBu contraction of cells to determine the effects on
active cytoskeletal remodeling and on PDBu-induced changes in cytoskeletal structure,
respectively. The effects of these inhibitors were examined in both α- and β-actin.
Inhibition of the kinase domain of MLCK caused a decrease in podosome formation in
cells stained for α-actin when added prior to PDBu or after PDBu indicating kinase
activity was essential for resting and PDBu-induced α-actin structure. By comparison,
the MLCK inhibitors had no effect on β-actin structure when added before PDBu
stimulation or after PDBu stimulation. The results allow no conclusions regarding the
role of the kinase domain of MLCK in the crosslinking of actin filaments by MLCK.
However, the results indicate that MLCK kinase activity is necessary for α-actin but not
β-actin cytoskeletal structure during the PDBu-induced contraction.
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Introduction
Myosin light chain kinase (MLCK) is a 130-150 kDa protein with a primary
function in smooth muscle of regulating contraction (Stull et al., 1998). MLCK is
activated by Ca2+/calmodulin (CaM) binding to specific sites on the protein (Kamm and
Stull, 1985). Once activated, MLCK phosphorylates the regulatory light chain of myosin
thereby activating the myosin ATPase and allowing the contraction to occur (Aksoy et
al., 1976; Chacko et al., 1977; DiSalvo et al., 1978; Gorecka et al., 1976; Ikebe et al.,
1977; Sobieszek 1977).
More recently, MLCK has been found to play a role in bundling actin filaments
(Hayakawa et al., 1994). MLCK contains two sites within its N-terminal region that bind
to actin (Ye et al., 1997) and can bind two different actin filaments to cross-link the actin
filaments into bundles (Hayakawa et al., 1994). The actin binding site between amino
acids 1-41 overlaps with a Ca2+/CaM binding site that regulates the interaction of MLCK
with actin at this site (Olson et al., 1990; Ye et al., 1997; Gao et al., 2001) and has been
referred to as the Ca2+/CaM sensitive binding site (Ye et al., 1997). The second actin
binding site is found between amino acids 138-218 (Ye et al., 1997; Gao et al., 2001).
Because this site is not affected by binding of Ca2+/CaM, it is referred to as the Ca2+/CaM
insensitive site (Ye et al., 1997; Gao et al., 2001). In the presence of Ca2+/CaM, actin is
released from the Ca2+/CaM sensitive site, which then allows it to interact with myosin in
the contractile process.
Previous work in our laboratory has indicated that MLCK is associated with both
α- and β-actin isoforms (Thatcher et al., 2007). MLCK was found to be closely
associated with α-actin along stress fibers in control cells as well as in podosomes of
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PDBu-induced contracted cells. MLCK was associated with β-actin stress fibers in
control cells and continued to be associated with β-actin in a diffuse manner around the
perinuclear region of the cell upon contraction of the cell with PDBu. Taken together,
this data indicates interaction of MLCK with both actin isoforms known to be present in
the A7r5 cell line, not merely the α-actin isoform thought to be involved in contraction of
smooth muscle cells.
The focus of this earlier work (Thatcher et al., 2007) centered on the effects of
inhibiting the N-terminal region of MLCK on actin organization. Through
downregulating MLCK using siRNA or by the addition of peptide containing amino acids
1-41 of MLCK either by microinjection or by peptide-mediated uptake, inhibition of the
N-terminal region of MLCK caused dissolution of α-actin stress fibers in the central
region of control A7r5 cells, while cells induced to undergo contraction by the addition of
phorbol 12, 13-dibutyrate (PDBu) exhibited a 70% reduction in podosome formation. βactin was found to disassemble with diffuse distribution of this isoform throughout the
cell when N-terminal inhibitors were introduced into control cells and PDBu treated cells.
The present study examines the role of the kinase domain of MLCK in the
structural organization of α- and β-actin in control and PDBu treated A7r5 cells. The
inhibitors ML-7 and ML-9, which inhibit MLCK by binding at the kinase domain, were
utilized to study the impact on actin cytoskeletal structure. α- and β-Actin structure were
examined with inhibitors added alone to determine the effects on control cells as well as
cells in which the inhibitors were added prior to and after the addition of PDBu to induce
contractile cytoskeletal remodeling. The idea behind the study was to determine if the
inhibition of kinase activity leading to changes in the internal tension within the cell had

76

similar effects on actin structure to that seen during inhibition of N-terminal actin binding
domains.
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Materials and Methods
Cell Culture
A7r5 smooth muscle cells, derived from embryonic rat aorta and shown to
maintain the ability to contract to phorbol esters (Fultz et al. 2000; Nakajima et al. 1993),
were obtained from American Type Culture Collection (Manasass, Va.). Cells were
plated on 75-cm2 flasks and grown to approximately 85% confluence at 37oC in a
humidified atmosphere of 5% CO2 in air. The cells were maintained in Dulbecco’s
modified Eagles medium (DMEM) supplemented with 10% fetal bovine serum, 100
U/mL penicillin G, and 100 µg/mL streptomycin. Media was changed every other day
and cells were passaged at least once a week. Passaging was accomplished by addition of
trypsin-EDTA solution in PBS and collection of cells by centrifugation.

Immunocytochemistry and Confocal Microscopy
In experiments employing immunostaining, cells were seeded onto glass
coverslips, placed in 6-well culture plates and returned to the incubator for a minimum of
24 h to allow for attachment and spreading. After experimental treatment, cells were
fixed and permeabilized by addition of ice cold acetone for 1 min. The cells were
washed with PBS containing 0.5% Tween-20 (PBS-T), pH 7.5, followed by a 30-min
incubation in blocking solution containing 5% nonfat dry milk in PBS. α-Actin staining
was accomplished by incubation of cells in a 1:500 dilution of monoclonal-α-smooth
muscle actin, clone 1A4 FITC-labeled antibody (Sigma Chemical Co., St. Louis, Mo.) for
60 min at room temperature. In order to visualize β-actin, a β-actin-EGFP expression
plasmid was purchased from Clontech (Palo Alto, CA). The green fluorescent protein-
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actin fusion protein has been successfully utilized in a wide range of cell types (Aizaws et
al., 1997; Faix et al., 1998; Noegel and Schleicher, 2000; Okada et al., 1999) and has
been shown to be a suitable probe for the study of actin organization and dynamics in
several mammalian cell lines (Choidas et al., 1998). Cells were transfected in culture
flasks with 2-6 µg of plasmid using lipofectamine (Life Technologies, Rockville, MD)
according to the manufacturer’s standard protocol. Fluorescence of the β-actin-GFP
fusion protein was typically observed within 2 days and experiments were performed
within 3 or 4 days after transfection. Cells were imaged by mounting on a Nikon Diaphot
Microscope and confocal microscopy performed with a Bio-Rad Model 1024 scanning
system with a Krypton/Argon laser. Micrographs were constructed by projection of Zplane acquisitions and analyzed by Lasersharp and Confocal Assistant Software (BioRad,
Hercules, Calif.).
Cell Treatments and Analysis of Actin Remodeling
MLCK inhibitors ML-7 and ML-9 were added at a final concentration of 10-5,
10-6, 10-7, or 10-8 M. The effect of the compounds were evaluated in their ability to alter
α-actin and β-actin structure both during PDBu-stimulated (10-7 M) reorganization and
after PBDu-induced reorganization was established. For the former experiments, an
inhibitor was added 30 min before PDBu with the cells fixed for imaging 30 min after
PDBu stimulation. For the latter, the inhibitor was added 30 min following PDBu with
cells fixed for imaging at 30 min after the introduction of inhibitor. Vehicle-control cells
were fixed at identical intervals as the inhibitor-treated cells.
To estimate losses in α- and β-actin stress fibers, confocal images of treated and
control cells were obtained at fixed confocal settings and analyzed using Image J
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software (NIH). Using the line scan tool, the cell was bisected in the long axis at midcell and the resulting plot was imported into Microsoft Office Excel (Fig. 1). The point
of lowest intensity was selected as baseline and the graph was then analyzed using
Peakfit 4.0 software to determine the area under the curve (I = total intensity). This value
was then divided by line pixel number (p) to normalize for line length. The final value,
β-actin filament intensity = I/p was calculated using Excel.
Cell counts were conducted on α-actin stained cells to determine changes in
podosome formation over the various concentrations and treatment groups. In each
treatment group, a minimum of 100 cells were counted in total noting the number of cells
that exhibited podosome formation. The counts were reported as a percentage of cells
that exhibited podosome formation. Cell counts were not conducted on β-actin cells.
Previous work (Brown et al., 2006) has indicated that cells treated with PDBu at a
concentration of 10 -7 M and stained for β-actin or transfected with the β-actin construct
exhibited podosomes in less than 20% of the cells. For this reason, cell counts were not
conducted, but rather stress fiber loss was evaluated.
Data Analysis
Analysis of differences between treatment means was performed by 1-way
ANOVA followed by Student’s unpaired t test (Sigma Stat, SPSS, Chicago, Ill.).
Differences between means were considered significant if p ≤ 0.05. Averaged results are
presented as mean ± SE throughout the text.
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Results
Previous work has revealed a marked difference in the response of α- and β-actin
to PDBu stimulation at a concentration of 10-7 M (Figure 1) (Fultz et al., 2000; Brown et
al., 2006). In control cells, both α- and β-actin are present in stress fibers that run the
length of the cell. Upon stimulation with PDBu, α-actin is found to lose stress fiber
structure with the majority of the stress fibers remodeling into podosomes around the
periphery of the cell. β-actin does not remodel into podosome structures but rather the
stress fibers appeared to shorten with the change in the size of the cell.
MLCK inhibitors were added prior to or after PDBu stimulation to evaluate their
effect on cytoskeletal remodeling or their effect on PDBu-induced changes in remodeled
structure, respectively. In order to examine the effects of ML-7 and ML-9 on α-actin
cytoskeletal structure, podosome formation was evaluated (data not shown). In cells
treated with inhibitors prior to PDBu stimulation, the percentage of cells exhibiting
podosomes decreased (Figure 2). The same trend was seen in cells treated with the
MLCK inhibitors after stimulation with PDBu (Figure 3). These results suggest that ML7 and ML-9 prevent podosome formation when added prior to PDBu stimulation and
reverse podosome formation when the inhibitors were added after PDBu stimulation.
To evaluate the effects of the inhibitors on β-actin stress fiber structure, filament
intensity of the cells was determined using line scan analysis (Table 1). In all treatment
groups except ML-7 at a concentration of 10-8 M, no significant differences were found
in the β-actin stress fiber structures when inhibitors were added before or after PDBu
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stimulation (Figure 4 and 5). It is unclear why 10-8 M ML-7 would result in a loss in βactin structure when added both before and after PDBu. The Ki for ML-7 is 300 nM and
10-8 M of the inhibitor would fall well below this concentration suggesting the results
reflect experimental artifact.
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Control

PDBu

α-actin

β-actin

Figure 1. Comparison of control and PDBu treated cells exhibiting α-actin or β-actin.
Control cells stained for α-actin exhibit numerous stress fibers running the length of the
cell. α-Actin stained cells treated with PDBu (10-7 M) exhibit robust podosome
formation around the periphery of the cell with loss of stress fiber structure. β-Actin
control cells also exhibit numerous stress fibers running the length of the cell. Cells
treated with PDBu (10-7 M) continue to show β-actin stress fibers running the length of
the cell without the presence of podosome formation.
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ML-7
10-5 M

10-6 M

10-7 M

10-8 M

Figure 2
84

ML-9

Figure 2. Cells stained for α-actin and treated with the MLCK inhibitors ML-7 or ML-9
30 minutes prior to PDBu stimulation. There is a trend for a decrease in podosome
formation within these cells suggesting the prevention of podosome formation.

85

ML-7
10-5 M

10-6 M

10-7 M

10-8 M

Figure 3
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ML-9

Figure 3. Cells stained for α-actin and treated with the MLCK inhibitors ML-7 or ML-9
for 30 minutes following PDBu stimulation. There is a trend for a decrease in podosomes
in these cells suggesting a reversal in podosome formation.
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ML-7

10-5 M

10-6 M

10-7 M

10-8 M

Figure 4
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ML-9

Figure 4. Cells stained for β-actin and treated with the MLCK inhibitors ML-7 or ML-9
for 30 minutes prior to PDBu stimulation. As indicated in table 1, with the exception of
10-8 M treatment, ML-7 had no effect on β-actin stress fibers.
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ML-7

10-5 M

10-6 M

10-7 M

10-8 M

Figure 5
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ML-9

Figure 5. Cells stained for β-actin and treated with the MLCK inhibitors ML-7 or ML-9
for 30 minutes after PDBu stimulation. As indicated in table 1, only with the exception
of 10-8 M treatment, ML-7 had no effect on β-actin stress fibers.
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Table 1. A comparison of the effects of ML-7 and ML-9 at varying concentrations on βactin structure of A7r5 cells when added before or after stimulation with PDBu.

Before PDBu

After PDBu

Pooled Control

100.0 ± 2.3

100.0 ± 2.3

PDBu

93.3 ± 2.2

93.3 ± 2.2

ML-7 10-8 M

84.6 ± 2.8*

84.6 ± 2.5*

ML-7 10-7 M

95.2 ± 2.5

101.6 ± 3.5

ML-7 10-6 M

107.4 ± 3.1

108.1 ± 3.7

ML-7 10-5 M

106.6 ± 3.3

101.8 ± 3.2

ML-9 10-8 M

92.9 ± 3.1

96.9 ± 3.8

ML-9 10-7 M

95.1 ± 3.0

106.4 ± 3.0

ML-9 10-6 M

92.2 ± 3.0

89.9 ± 2.6

ML-9 10-5 M

90.8 ± 3.2

92.0 ± 2.9

Note: Inhibitors were added 30 min before stimulation with PDBu (10-7 M) to evaluate
their effect on active cytoskeletal remodeling or 30 min after PDBu to evaluate their
effect on PDBu-induced changes in remodeled structure. Results are based on cell line
scans measureing fluorescence intensity as an index of β-actin stress fiber structure.
Values are expressed as percent of values obtained from PDBu-stimulated inhibitor
vehicle controls. * p < 0.05 vs. pooled control
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Discussion
The concept of a dual role of MLKC in smooth muscle contraction was a novel
hypothesis first proposed by our laboratory. In addition to its kinase properties enabling
force development through the interaction of myosin and actin filaments, we proposed
that MLCK actin binding could maintain the actin/myosin contractile machinery in
opposition in the resting cell and release tension bearing actin filaments upon activation
of MLCK, allowing sliding filament dynamics and contractile remodeling. Because of
the novelty of this hypothesis very little information is available in the literature.
In initial studies examining MLCK actin binding (Thatcher et al., 2007), MLCK
was shown to be closely associated with both α- and β-actin in control and PDBu-treated
cells by means of colocalization and fluorescence resonance energy transfer (FRET)
analysis. Next, MLCK was downregulated 40-55% with the introduction of MLCKsiRNA. Upon downregulation of MLCK, cells demonstrated a loss in stress fiber
structure and rounding of the cell. In cells stained with α-actin, the central region of the
cells were devoid of stress fibers, while the periphery of the cells demonstrated a network
of α-actin stress fibers. β-Actin stained cells, on the other hand, generally lacked stress
fibers all together with β-actin forming a network in the perinuclear region of the cell.
Cells treated with PDBu demonstrated both isoforms relocating to podosomes around the
periphery of the cell in negative control cells. However, cells treated with MLCK-siRNA
showed a nearly 70% reduction in podosome formation and resembled cells treated with
MLCK-siRNA without being stimulated with PDBu.
Another set of experiments were conducted introducing peptides containing
sequences overlapping the actin binding domains of MLCK into A7r5 cells to
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competitively inhibit actin binding. Two sets of peptides were used. One set contained
the amino acids 1-41, while the other set only contained the amino acids 1-25. The
second set of peptides had no effect on control or PDBu treated cells stained for α- actin.
However, introduction of the 1-41 peptides into cells either by microinjection or by
peptide-mediated uptake caused the same results found in the MLCK-siRNA
experiments. This work indicated the Ca2+/CaM insensitive actin binding site of MLCK
showed to cause crosslinking of actin stress fibers played a role in determining actin
structure. The crosslinking role of MLCK appears to be important in maintaining the
actin structure in resting cells possibly by stabilizing the actin stress fibers. It is thought
that during Ca2+-dependent contraction MLCK releases actin at the Ca2+/CaM sensitive
binding site to allow actin to be moved by myosin contributing to force development. In
a Ca2+-independent contraction, such as that produced by phorbol, actin is not released
from MLCK, which may be important to remodeling of actin during PDBu induced
contractions. In any case, the results from Thatcher et al., (2007) provided compelling
evidence that actin filament binding by MLCK plays a major role in actin structural
arrangement in the cell before and during contraction by PDBu.
While our early results indicated MLCK contributes to the stabilization and
remodeling of actin in control and PDBu treated cells, whether this effect was due
exclusively to non-kinase properties of MLCK was not certain. As mentioned by
Thatcher et al., (2007), it is possible that a loss in basal kinase activity of MLCK could
lead to loss of stress fiber structure if MLCK is responsible for maintaining some internal
strain in the cell. Chrzanowska-Wodnicka and Burridge (1996) have found stress fiber
formation in the presence of internal strain. Therefore, it was of interest to determine if
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inhibition of MLCK kinase activity and possible tension development caused changes in
actin cytoskeletal structures similar or different from the results of Thatcher et al., (2007).
If the results were found to be similar, it would suggest that MLCK binding of actin
filaments was essential for tension development and through this mechanism, influenced
cytoskeletal structure.
In the current studies, MLCK inhibitors showed a trend in decreasing the number
of cells that exhibited α-actin remodeling to podosomes, which is in agreement with the
findings in Thatcher et al., (2007) where inhibition of the Ca2+/CaM insensitive actin
binding site caused a decrease in podosome formation by approximately 70%. The two
sets of data taken together suggest that the crosslinking of α-actin by MLCK combined
with tension development could influence α-actin remodeling during PDBu-induced
contraction.
However, inhibition of the kinase domain had no consistant effect on β-actin,
structure. This result differs from the results of Thatcher et al., (2007) concerning β-actin
and the inhibition of the Ca2+/CaM insensitive actin binding site which caused dissolution
of β-actin fibers resulting in diffuse staining of the cell for β-actin. And while the
interaction of MLCK and α-actin could play an important role in tension development
and cytoskeletal remodeling during PDBu-induced contraction, it appears that the
interaction of MLCK and β-actin does not require kinase activity or tension development
for structural integrity.
The results taken together seem to point to a role for the crosslinking of α-actin
by MLCK in tension development and cytoskeletal remodeling in contraction of the A7r5
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cell. Thatcher et al. (2007) suggests a model for the crosslinking of actin by MLCK and
the role it plays in Ca2+ dependent smooth muscle contraction. The model proposes that
MLCK binds to α-actin by the Ca2+/CaM sensitive actin binding site and to β-actin by the
Ca2+/CaM insensitive binding site. With the efflux of Ca2+, Ca2+ complexes with
calmodulin to interact with MLCK causing release of α-actin by MLCK. The release of
actin in close association with myosin and simultaneous phosphorylation of myosin
allows crossbridge cycling in the absence of sarcomere structure found in other muscle
types. The present results suggest this model may be feasible for explaining the
interaction of MLCK and α-actin but not β-actin.
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Chapter IV
Summary and Conclusions
General Discussion
Two isoforms of actin have been found to be present in vascular smooth muscle
cells. It has long been thought that only the α-actin isoform takes part in the contraction
of the cell, while β-actin is present only to support structure within the cell. However, if
the concentration of PDBu is high enough, β-actin will remodel into podosomes around
the periphery of the cell in the same manner α-actin remodels at much lower
concentrations of PDBu. At a concentration of 10-7 M PDBu, which activates a
physiological level of PKC to cause contraction, α-actin is found to remodel into
podosomes in about 70% of the cells, while β-actin was found to remodel into
podosomes in only 20% of the cells. Staining the cells with phalloidin to label all actin
filaments and DNase I to label globular actin showed a decrease in filamentous actin with
no change in globular actin. Examining the amount of filamentous and globular actin in
control and PDBu treated cells by Western Blot analysis indicated no change in
filamentous actin in PDBu-treated cells, suggesting phalloidin is unable to reach and be
detected in the tightly packed actin found in the core of the podosome. This marked
dichotomy in actin isoform remodeling suggests differential regulation of the actin
isoforms during smooth muscle contraction.
Treating the cells with PKC inhibitors, staurosporine and bisindolymaleimide,
prior to and after PDBu stimulation, showed an inhibition of α-actin remodeling to
podosomes when added prior to PDBu stimulation and reversed podosome formation
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with re-establishment of stress fibers when added after PDBu stimulation. β-actin was
evaluated based on stress fiber structure and exhibited a loss in stress fiber structure when
the PKC inhibitors were added prior to or after PDBu stimulation. The results from these
studies indicate differential isoform reorganization during PDBu contraction, as well as
different modes of regulation of the two actin isoforms structure.
Another protein important in smooth muscle contraction is MLCK. MLCK is
well known as the enzyme involved in the initiation of smooth muscle contraction in
Ca2+- dependent contractions. MLCK has also recently been found to crosslink actin
filaments. The crosslinking of actin is considered a non-kinase function of the enzyme.
We wanted to determine if the kinase domain and tension development played a role in
MLCK binding to actin and contractile remodeling of actin structure by using two
inhibitors of MLCK, ML-7 and ML-9. These inhibitors were found to cause a decrease
in podosome formation in cells stained with α-actin when added prior to or after PDBuinduced contraction. The use of the inhibitors in cells expressing β-actin did not show a
change in β-actin structure when the inhibitors were added prior to or after PDBu
stimulation. Therefore, the kinase domain of MLCK and tension development appears to
play a role in cytoskeletal remodeling of α-actin in the contracting A7r5 cell. However,
the kinase domain of MLCK with tension development does not seem to have an effect
on β-actin structure during contraction of the A7r5 cell.

Future Studies
With so many avenues left to explore in smooth muscle contraction, there are an
endless number of proteins that could play a role in the regulation of α- and β-actin.
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Another protein that we have done a little work with is Rho kinase. Rho kinase is a
member of a signaling cascade that is thought to play a role in actin filament assembly
and possibly a role in bundling actin filaments (Tang and Anfinogenova, 2008).
Another avenue to explore is to determine how α-actin remodels into podosomes.
Our lab has done some live cell, time course studies examining β-actin during contraction
of the cell since it is a GFP-labeled protein. Attempts have been made to replicate these
experiments using a tagged α-actin with no success because of the inability to make a
construct to express the tagged protein. It is uncertain whether α-actin depolymerizes
and repolymerizes at podosomes, or if the actin is taken into the podosome core as a
filamentous actin. Such a construct could shed light on this subject.

Refereneces
Tang D. and Anfinogenova Y. 2008. Physiological properties and regulation of the actin
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